×
MedSchool: Ace Your OSCEsThe Medical Company
 
 
 
 
 
GET - On the App Store
View
Drug Guide
 
 

Linagliptin

 
Bookmark
  •  
    Oral
    Linagliptin
    Trajenta 
  • Mechanism of Action

  • Stimulates insulin secretion by inhibiting dipeptidyl peptidase-4 (DPP-4), an enzyme that normally degrades incretin hormones.
  • Pharmacology

  • Stimulates insulin secretion in hyperglycaemia, and Inhibits glucagon secretion in hyperglucagonaemia.

Clinical Use

  • Indications

  • Glycaemic control for type II diabetes
  • Adverse Effects
  • URTI
  • Headache
  • Pancreatitis
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now
   
 
 

Snapshot: Initialising...